Delivery Order SPE2DB22D1202-SPE2DB25FUGM5
Award Date
10/25/24
Potential Completion Date
10/28/24
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36mg Concerta ER Tablets, a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has a ceiling value of $10,059.75 and a performance period ending on May 8, 2025. The contract is a firm fixed-price delivery order and is not set aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,597.36 firm fixed-price contract is for the delivery of Concerta ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,965.46 firm fixed-price contract is for the delivery of Concerta ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Concerta ER 36 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $10,795.92 and a performance period ending on May 5, 2025. It is a firm-fixed-price contract, meaning the price will not change regardless of the contractor's costs. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Concerta ER 18 mg tablets, a specialty medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $11,442.83 and an ultimate completion date of June 3, 2024. This order is part of a broader...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,139.86, is for the supply of Concerta ER 27 mg tablets, a controlled-release formulation of the stimulant medication methylphenidate used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed-price pricing structure and an ultimate completion date...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,961.18, is for the delivery of Concerta ER Tabs 36mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 18 mg Concerta ER tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The firm fixed-price contract has a ceiling value of $15,471.02 and a period of performance through May 20, 2025. The contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,654.80, is for the delivery of Concerta ER Tabs 27mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract covers the delivery of Concerta ER 36 mg tablets, a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). The delivery order has a ceiling value of $7,108.57 and a completion date of May 3, 2023. The contract is a firm-fixed-price type...